Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
30.78
+0.07 (0.23%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 674 employees as of December 31, 2024. The number of employees increased by 22 or 3.37% compared to the previous year.
Employees
674
Change (1Y)
22
Growth (1Y)
3.37%
Revenue / Employee
$981,924
Profits / Employee
$109,592
Market Cap
1.72B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
SUPN News
- 6 weeks ago - Supernus to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Supernus to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 7 weeks ago - Supernus Pharmaceuticals, Inc. (SUPN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Supernus Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - BREAKING: Supernus Pharmaceuticals, Inc. Shares Down 14%; Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm's Investigation - GlobeNewsWire
- 2 months ago - Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial - Benzinga
- 2 months ago - Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression - GlobeNewsWire
- 2 months ago - Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire